Dr. Ted Johnson is leading a clinical trial in pediatric cancer research based on immunotherapy discoveries at MCG.

The Augusta Chronicle: Cancer therapy trial draws children from across nation

A clinical trial at the Georgia Cancer Center at Augusta University featuring a homegrown discovery is drawing kids from other prestigious cancer centers across the country. These children are being treated with Indoximod, an inhibitor of the enzyme known as IDO, whose role in inhibiting an immune response was first discovered at the Medical College of Georgia in 1998 by a team of researchers led by Drs. David Munn and Andrew Mellor.

The trial also was helped by the arrival of another homegrown product in Dr. Ted Johnson, who got his MD/Ph.D from MCG in 2004 and had Mellor as his advisor when he was doing his doctoral thesis on IDO. His preclinical work on brain tumors and IDO helped set up the trial, and Johnson also received grant funding to move the trial forward.

Read the full story.

The Augusta Chronicle: Augusta cancer therapy trial draws children from across nation
Oct. 9, 2016
Like
Like Love Haha Wow Sad Angry
Avatar
Written by
Steven Uhles

Steven Uhles is Director of Media and Marketing for the Georgia Cancer Center. Contact him to schedule an interview on this topic or with one of our experts at 706-723-0096 or suhles@augusta.edu.

View all articles
Avatar Written by Steven Uhles

Jagwire is your source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia.

Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences.